Cargando…
Type 2 Diabetes and ADP Receptor Blocker Therapy
Type 2 diabetes (T2D) is associated with several abnormalities in haemostasis predisposing to thrombosis. Moreover, T2D was recently connected with a failure in antiplatelet response to clopidogrel, the most commonly used ADP receptor blocker in clinical practice. Clopidogrel high on-treatment plate...
Autores principales: | Samoš, Matej, Fedor, Marián, Kovář, František, Mokáň, Michal, Bolek, Tomáš, Galajda, Peter, Kubisz, Peter, Mokáň, Marián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707344/ https://www.ncbi.nlm.nih.gov/pubmed/26824047 http://dx.doi.org/10.1155/2016/6760710 |
Ejemplares similares
-
The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study
por: Samoš, Matej, et al.
Publicado: (2016) -
Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences
por: Samoš, Matej, et al.
Publicado: (2017) -
Role of Thromboelastography and Rotational Thromboelastometry in the Management of Cardiovascular Diseases
por: Korpallová, Barbora, et al.
Publicado: (2018) -
Sticky platelets syndrome in a young patient with massive pulmonary embolism
por: Darulová, Stanislava, et al.
Publicado: (2013) -
Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?
por: Škorňová, Ingrid, et al.
Publicado: (2021)